Biotest

Biotest EBITDA

Delisted

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Biotest (BIO.DE) as of Nov 6, 2026 is 103.90 M EUR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 151.90 M EUR — a change of -31.60% (lower).

EBITDA

103.90 MEUR

YoY

-31.60%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Biotest is 2024 103.90 M EUR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Biotest was 2023 151.90 M EUR. It decreases by -31.60% lower compared to the previous year.

The Biotest EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2017
-1.80 M EUR
Jan 1, 2018
18.00 M EUR
Jan 1, 2019
19.90 M EUR
Jan 1, 2020
-5.90 M EUR
Jan 1, 2021
-40.30 M EUR
Jan 1, 2022
-2.60 M EUR
Jan 1, 2023
151.90 M EUR
Jan 1, 2024
103.90 M EUR
The Biotest EBITDA history
YEAREBITDAYoY
103.90 MEUR-31.60%
151.90 MEUR-5,942.31%
-2.60 MEUR-93.55%
-40.30 MEUR+583.05%
-5.90 MEUR-129.65%
19.90 MEUR+10.56%
18.00 MEUR-1,100.00%
-1.80 MEUR-104.19%
43.00 MEUR-5.29%
45.40 MEUR-27.24%
62.40 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Biotest Stock analysis

What does Biotest do? Biotest AG is an innovative and successful company that operates in the fields of medicine, pharmacy, and biotechnology. It was founded in 1946 by Dr. Carl Adolf Vorherr in Dreieich near Frankfurt am Main. The company's original focus was on the development, production, and distribution of blood plasma products. In the 1950s, Biotest expanded into the field of transfusion medicine and began to clinically examine and process blood from donors. It became a leading manufacturer of concentrate preparations for the treatment of immune deficiencies and blood coagulation disorders in the 1960s. In the 1970s, the company became a leading manufacturer of monoclonal and polyclonal antibodies and an important research and development facility for biotechnological applications. Biotest today is divided into five research and business areas: Hematology & Immunology, Clinical Immunology, Biotherapeutics, Dermatology, and Research and Development. The company is globally present with locations in Europe, North America, Asia, and South America. It employs over 2,500 people and its products are available in more than 90 countries. It invests in research and development to stay at the forefront of technology and improve global health. Biotest is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biotest stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Biotest is 103.90 M EUR in 2024.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Biotest changed from 151.90 M EUR to 103.90 M EUR, representing a -31.60% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Biotest since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Biotest historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Biotest

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Biotest